CGD Policy Blogs




Prospects for new vaccines

The American Academy of Microbiology has published a new report obn vaccines, current infectious disease problems, the potential for new and better vaccines, vaccine safety, research issues surrounding vaccines, and education and training topics.

The report assesses the prospects of selected new vaccine developments as follows:

Making Markets for Vaccines Brief Translated

The Making Markets for Vaccines - Ideas to Action (Brief) has been translated for download (PDF) in Canadian French, German, Italian, Japanese, Russian and Spanish.

You can see the translated briefs here.

Schelling and Aumann Nobel Prize for Economics

It was announced today that Thomas C. Schelling and Robert J. Aumann were awarded the Nobel Prize for Economics today. You are probably wondering what this has got to do with vaccines?

One of Schelling's most important ideas is the value of precommitment. He has written about how you can be better off, either individually, or institutionally, if your choices are limited in advance.

Vaccines Against Cervical Cancer Soon But Will It Be Enough?

Merck and GlaxoSmithKline have been conducting trials of vaccines that protect against the human papilloma virus.

Two forms of human papillomavirus, types 16 and 18, are responsible for an estimated 70 percent of cervical cancer cases. Such cancers kill about 300,000 women worldwide each year, including almost 4,000 in the United States.

Vaccine Industry on the Road to Recovery?

Drug Discovery and Development Magazine has an upbeat article which argues that vaccines are on the road to recovery.

Patrick McGee notes that times have been tough for the vaccine industry:

Dengue Fever Epidemic in Asia

While the world anxiously prepares for an avian flu epidemic, Dengue Fever is sweeping Asia. At least 127,000 people have been infected by dengue so far this year from eastern India to Indonesia and the Philippines, with at least 990 deaths.

HIV Virus Becoming Less Aggressive

The HIV virus is becoming less aggressive, researchers have said in a new study,

Researchers at the Institute of Tropical Medicine in Antwerp, Belgium, compared HIV-1 samples from 1986-89 and 2002-03 and found that 75 per cent of the newer samples appeared less fit than those of 15 years ago both in terms of spread within individuals and transmission to others.